Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2025-12-25 @ 2:09 AM
NCT ID:
NCT07042360
Eligibility Criteria:
Inclusion Criteria:
* Patients with \>=moderate TR
* able to consent for the study.
Exclusion Criteria:
1. LVEF \<=40%
2. Have significant left sided organic valvular heart disease (i.e. \>=moderate AS, \>=moderate MS, \>=moderate MR of organic or mixed aetiology), dysfunctional mitral valve replacement or aortic valve replacement
3. Prior tricuspid valve interventions (eg TriClip, tricuspid valve repair or replacement) (To allow accurate transient elastography)
4. Known hepatocellular carcinoma
5. Known portal vein thrombosis
6. Established liver cirrhosis with a known liver-related aetiology
7. Hepatitis C infection and not on treatment
8. Uncontrolled hepatitis (e.g. hepatitis B infection, autoimmune hepatitis)
9. Fatty liver with evidence of non-alcoholic fatty liver disease or cirrhosis (to allow accurate non-invasive lung fluid assessment)
10. recent rib fracture (\<3 months) with or without flail chest
11. BMI \<20 or \>36
12. Height \<155cm or \>195cm
13. Patients with right lung tumor
14. Patients with right sided pacemaker
15. Patients with known underlying exudative right pleural effusion
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07042360
Study Brief:
Protocol Section:
NCT07042360